THE TREATMENT OF SEVERE ALLERGIC ASTHMA WITH OMALIZUMAB

  • Kristina Biekšienė
DOI: https://doi.org/10.37499/PIA.173
Keywords: omalizumab, severe allergic asthma, eosinophil

Abstract

Omalizumab is effective for the treatment of severe allergic asthma irrespective of pre-treatment blood eosinophil count. Omalizumab decreases the rate of exacerbation, the dose of systemic and inhaled gliucocorticoids, increases the quality of life. Treatment with omalizumab safe, effectiveness long term, besides is the possibility to treat children.

Author Biography

Kristina Biekšienė

Department of Pulmonology, Medical Academy, Lithuanian University of Health Sciences

How to Cite
1.
Biekšienė K. THE TREATMENT OF SEVERE ALLERGIC ASTHMA WITH OMALIZUMAB [Internet]. PIA 2018 Sep.;2(2):156-160.[cited 2024 May 19 ] Available from: http://pia.pulmoalerg.lt/index.php/PIA/article/view/173
Issue
Vol 2 No 2 (2018): Pulmonology and Allergology
Section
Pharmacotherapy